Deutsche Bank Ag\ Sarepta Therapeutics, Inc. Transaction History
Deutsche Bank Ag\
- $262 Billion
- Q2 2025
A detailed history of Deutsche Bank Ag\ transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 134,078 shares of SRPT stock, worth $2.29 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
134,078
Previous 1,663,573
91.94%
Holding current value
$2.29 Million
Previous $106 Million
97.84%
% of portfolio
0.0%
Previous 0.04%
Shares
39 transactions
Others Institutions Holding SRPT
# of Institutions
463Shares Held
83.3MCall Options Held
5.6MPut Options Held
4.19M-
Black Rock Inc. New York, NY10.3MShares$176 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.16MShares$156 Million0.0% of portfolio
-
State Street Corp Boston, MA4.7MShares$80.1 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY4.48MShares$76.4 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA2.53MShares$43.1 Million0.01% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $1.49B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...